ZA976196B - Peptide reagent for the detection of human cytomegalovirus (cmv) - Google Patents
Peptide reagent for the detection of human cytomegalovirus (cmv)Info
- Publication number
- ZA976196B ZA976196B ZA976196A ZA976196A ZA976196B ZA 976196 B ZA976196 B ZA 976196B ZA 976196 A ZA976196 A ZA 976196A ZA 976196 A ZA976196 A ZA 976196A ZA 976196 B ZA976196 B ZA 976196B
- Authority
- ZA
- South Africa
- Prior art keywords
- cmv
- detection
- antibodies
- human cytomegalovirus
- peptide reagent
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 238000001514 detection method Methods 0.000 title abstract 4
- 241000701024 Human betaherpesvirus 5 Species 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 title abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 4
- 239000012530 fluid Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/088—Varicella-zoster virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/089—Cytomegalovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96201972 | 1996-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA976196B true ZA976196B (en) | 1998-09-01 |
Family
ID=8224180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA976196A ZA976196B (en) | 1996-07-12 | 1997-07-11 | Peptide reagent for the detection of human cytomegalovirus (cmv) |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6936251B2 (xx) |
| EP (1) | EP0960336B1 (xx) |
| JP (1) | JP4218985B2 (xx) |
| KR (1) | KR100624517B1 (xx) |
| AT (1) | ATE225942T1 (xx) |
| AU (1) | AU735981B2 (xx) |
| DE (1) | DE69716305T2 (xx) |
| DK (1) | DK0960336T3 (xx) |
| ES (1) | ES2187796T3 (xx) |
| ID (1) | ID19063A (xx) |
| WO (1) | WO1998002746A1 (xx) |
| ZA (1) | ZA976196B (xx) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19919121B4 (de) * | 1999-04-27 | 2012-08-02 | F. Hoffmann-La Roche Ag | Multimeres CMV-Antigen |
| EP1328540B1 (en) * | 2000-10-20 | 2005-03-23 | City of Hope | Immunoreactive peptidic ctl epitopes of human cytomegalovirus pp150 |
| AUPR593101A0 (en) * | 2001-06-26 | 2001-07-19 | Council Of The Queensland Institute Of Medical Research, The | Cytomegalovirus t cell epitopes |
| ITMI20012160A1 (it) * | 2001-10-18 | 2003-04-18 | Edoardo Marchisio | Sistema immunoenzimatico per la caratterizzazione antigenica dell'infezione attiva da cytomegalovirus e cmv confirmation test |
| GB0700133D0 (en) | 2007-01-04 | 2007-02-14 | Humabs Llc | Human cytomegalovirus neutralising antibodies and use thereof |
| US7947274B2 (en) | 2007-01-04 | 2011-05-24 | Humabs, LLC. | Human cytomegalovirus neutralising antibodies and use thereof |
| CN101605808A (zh) * | 2007-02-07 | 2009-12-16 | 希格马托制药工业公司 | 人巨细胞病毒(hcmv)的重组抗原 |
| MX343490B (es) | 2008-07-16 | 2016-11-08 | Inst For Res In Biomedicine | Anticuerpos neutralizantes de citomegalovirus humano y uso de los mismos. |
| US20120093848A1 (en) * | 2009-06-26 | 2012-04-19 | Vectorite Biomedica Inc. | Immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof |
| JP5712513B2 (ja) * | 2010-07-07 | 2015-05-07 | 富士レビオ株式会社 | ヒトサイトメガロウイルス感染の検出方法 |
| NZ591514A (en) * | 2011-03-03 | 2013-11-29 | Kode Biotech Ltd | Assay method |
| US10611800B2 (en) | 2016-03-11 | 2020-04-07 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| US11629172B2 (en) | 2018-12-21 | 2023-04-18 | Pfizer Inc. | Human cytomegalovirus gB polypeptide |
| US11857622B2 (en) | 2020-06-21 | 2024-01-02 | Pfizer Inc. | Human cytomegalovirus GB polypeptide |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0248909B1 (en) * | 1985-12-06 | 1994-08-17 | Teijin Limited | Anticytomegaloviral human monoclonal antibody and process for its preparation |
| CA1335429C (en) * | 1986-03-07 | 1995-05-02 | Geoffrey L. Smith | Processes for the production of hcmv glycoproteins, antibodies thereto and hcmv vaccines, and recombinant vectors therefor |
| DE3619902A1 (de) * | 1986-06-13 | 1988-03-03 | Biotechnolog Forschung Gmbh | Cmv-dna-strukturen, expressionsvektor dafuer, cmv-proteinstrukturen und deren verwendung |
| EP0330051B1 (de) * | 1988-02-24 | 1996-01-03 | BEHRINGWERKE Aktiengesellschaft | Strukturelles Phosphoprotein (pp28) des menschlichen Cytomegalovirus (HCMV), seine Herstellung und Verwendung |
| GB9014652D0 (en) * | 1990-07-02 | 1990-08-22 | Wellcome Found | Antigen |
| DE4128684A1 (de) | 1991-08-29 | 1993-03-04 | Behringwerke Ag | Hcmv-spezifische peptide, mittel dazu und ihre verwendung |
| US5744298A (en) * | 1991-08-29 | 1998-04-28 | Behringwerke Aktiengesellschaft | DNA sequences which encode immunoreactive HCMV-specific peptides |
| IT1266740B1 (it) * | 1994-07-01 | 1997-01-14 | Maria Paola Landini | Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale |
| EP0702083A3 (de) * | 1994-07-26 | 1997-01-15 | Biotest Ag | Polypeptide und Fusionsproteine bestehend aus dem UL 57 Leserahmen bzw. dem C-terminalen Bereich des Tegumentproteins pp150 aus HCMV, entsprechende Oligonucleotide und Nachweis reagentien |
| DE4426453C1 (de) * | 1994-07-26 | 1995-11-02 | Biotest Ag | Rekombinant hergestellte Fusionsproteine des Cytomegalievirus und diese enthaltende diagnostische Testkits |
-
1997
- 1997-07-09 EP EP97932819A patent/EP0960336B1/en not_active Expired - Lifetime
- 1997-07-09 DK DK97932819T patent/DK0960336T3/da active
- 1997-07-09 AU AU36231/97A patent/AU735981B2/en not_active Expired
- 1997-07-09 ES ES97932819T patent/ES2187796T3/es not_active Expired - Lifetime
- 1997-07-09 JP JP50560998A patent/JP4218985B2/ja not_active Expired - Lifetime
- 1997-07-09 KR KR1019997000160A patent/KR100624517B1/ko not_active IP Right Cessation
- 1997-07-09 WO PCT/EP1997/003717 patent/WO1998002746A1/en active IP Right Grant
- 1997-07-09 DE DE69716305T patent/DE69716305T2/de not_active Expired - Lifetime
- 1997-07-09 AT AT97932819T patent/ATE225942T1/de not_active IP Right Cessation
- 1997-07-11 ZA ZA976196A patent/ZA976196B/xx unknown
- 1997-07-14 ID IDP972439A patent/ID19063A/id unknown
-
2002
- 2002-11-05 US US10/288,220 patent/US6936251B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US6936251B2 (en) | 2005-08-30 |
| KR20000023701A (ko) | 2000-04-25 |
| DE69716305T2 (de) | 2003-06-26 |
| JP2000514300A (ja) | 2000-10-31 |
| EP0960336B1 (en) | 2002-10-09 |
| ID19063A (id) | 1998-06-11 |
| WO1998002746A1 (en) | 1998-01-22 |
| US20030119039A1 (en) | 2003-06-26 |
| ES2187796T3 (es) | 2003-06-16 |
| JP4218985B2 (ja) | 2009-02-04 |
| KR100624517B1 (ko) | 2006-09-18 |
| ATE225942T1 (de) | 2002-10-15 |
| AU3623197A (en) | 1998-02-09 |
| DE69716305D1 (de) | 2002-11-14 |
| EP0960336A1 (en) | 1999-12-01 |
| DK0960336T3 (da) | 2003-02-10 |
| AU735981B2 (en) | 2001-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA976196B (en) | Peptide reagent for the detection of human cytomegalovirus (cmv) | |
| EP1104887A3 (en) | A method and test kit for assaying collagen fragments in body fluids | |
| BR9809443A (pt) | Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão. | |
| BR9712298A (pt) | Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão | |
| SE9500023D0 (sv) | Method of detecting cancer | |
| HUP0103650A2 (hu) | Vírusburok-proteinek epitópjai és az ellenük termelt ellenanyagok alkalmazása HCV-vírusantigén gazdaszövetből történő kimutatására | |
| WO2002008767A3 (en) | Methods and kits for sequencing polypeptides | |
| EP2275818A3 (de) | Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers | |
| ATE258310T1 (de) | Testverfahren für collagenpeptid | |
| GR3018371T3 (en) | Method for identifying or determining proteins and applications therefor. | |
| AU2002223044A1 (en) | Kit and method for detecting the esm-1 protein | |
| WO2001061305A3 (en) | Immunoassays detecting or making use of at least two rubber latexallergens | |
| WO1995014778A3 (en) | Dna sequence coding for a bmp receptor | |
| AU5479396A (en) | Epstein-Barr virus peptides and antibodies against these peptides | |
| EP1652918A3 (en) | Methods for detecting protein interactions using conformationally constrained peptides | |
| WO2000007024A3 (en) | Method of protein analysis | |
| DK0607425T3 (da) | Epstein-Barr-viruspeptider og antistoffer mod disse peptider | |
| CA2259967A1 (en) | Peptide reagent for the detection of human cytomegalovirus (cmv) | |
| NO983984L (no) | Disintegrin-metalloprotease samt anvendelse derav | |
| ATE228249T1 (de) | Immuntest zum nachweis von menschlichen cytomegalovirus spezifischen igm | |
| WO2001015655A3 (en) | Peptides and substances, methods and devices using same for diagnosing and treating neurodegenerative disorders | |
| AU6642698A (en) | Immunoassay and kit for iga antibodies specific for acetaldehyde adducts | |
| NO994056L (no) | Anvendelse av disintegrin metalloprotease samt mutanter og fragmenter derav |